These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16757278)

  • 1. A safe immunosuppressive protocol in adult-to-adult living related liver transplantation.
    Gruttadauria S; Cintorino D; Piazza T; Mandala L; Doffria E; Musumeci A; Di Trapani G; Arcadipane A; Scianna G; Spada M; Verzaro R; Volpes R; Vizzini G; Palazzo U; Minervini M; Marsh JW; Marcos A; Gridelli B
    Transplant Proc; 2006 May; 38(4):1106-8. PubMed ID: 16757278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation.
    Gruttadauria S; Vasta F; Mandalà L; Cintorino D; Piazza T; Spada M; Verzaro R; Gridelli B
    Transplant Proc; 2005; 37(6):2611-3. PubMed ID: 16182762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients.
    Marino IR; Doria C; Scott VL; Foglieni CS; Lauro A; Piazza T; Cintorino D; Gruttadauria S
    Transplantation; 2004 Sep; 78(6):886-91. PubMed ID: 15385809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of basiliximab induction therapy in adult-to-adult living-related transplantation and deceased donor liver transplantation: a comparative retrospective analysis of a single-center series.
    Viganò J; Gruttadauria S; Mandalà L; Petridis I; Cintorino D; Li Petri S; Varotti G; Minervini M; Volpes R; Biondo D; Vizzini G; Marsh WJ; Marcos A; Gridelli B
    Transplant Proc; 2008; 40(6):1953-5. PubMed ID: 18675099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months.
    Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
    Transplant Proc; 2006 Dec; 38(10):3633-5. PubMed ID: 17175352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of basiliximab in the prevention of acute cellular rejection in adult to adult living-related liver transplantation: a single center experience.
    Gruttadauria S; Mandalà L; Biondo D; Spampinato M; Lamonaca V; Volpes R; Vizzini G; Marsh J; Marcos A; Gridelli B
    Biologics; 2007 Mar; 1(1):69-73. PubMed ID: 19707350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.
    Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR
    J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage.
    Liu CL; Fan ST; Lo CM; Chan SC; Ng IO; Lai CL; Wong J
    Liver Transpl; 2004 Jun; 10(6):728-33. PubMed ID: 15162466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients.
    Calmus Y; Scheele JR; Gonzalez-Pinto I; Jaurrieta EJ; Klar E; Pageaux GP; Scudamore CH; Cuervas-Mons V; Metselaar HJ; Prestele H; Girault D
    Liver Transpl; 2002 Feb; 8(2):123-31. PubMed ID: 11862588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
    Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G
    Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Tacrolimus without Basiliximab in Well-Matched Living-Donor Renal Transplant Recipients in Korea.
    Baek CH; Kim JH; Yu H; Shin E; Cho H; Kim H; Yang WS; Han DJ; Park SK
    Exp Clin Transplant; 2016 Aug; 14(4):389-93. PubMed ID: 27228054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renal-sparing efficacy of basiliximab in adult living donor liver transplantation.
    Lin CC; Chuang FR; Lee CH; Wang CC; Chen YS; Liu YW; Jawan B; Chen CL
    Liver Transpl; 2005 Oct; 11(10):1258-64. PubMed ID: 16184544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial immunosuppression with or without basiliximab: a comparative study.
    Martín-Mateos RM; Graus J; Albillos A; Arocena C; Rodríguez Gandía MA; Blesa C; García-Hoz F; García González M; García-Alonso FJ; Bárcena R
    Transplant Proc; 2012 Nov; 44(9):2570-2. PubMed ID: 23146457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of basiliximab induction immunosuppression in pediatric liver transplant recipients.
    Ganschow R; Grabhorn E; Schulz A; Von Hugo A; Rogiers X; Burdelski M
    Pediatr Transplant; 2005 Dec; 9(6):741-5. PubMed ID: 16269045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basiliximab versus steroids in double therapy immunosuppression in liver transplantation: a prospective randomized clinical trial.
    Lupo L; Panzera P; Tandoi F; Carbotta G; Giannelli G; Santantonio T; Rendina M; Gentile A; Memeo V
    Transplantation; 2008 Oct; 86(7):925-31. PubMed ID: 18852657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the cellular pharmacodynamics of tacrolimus in renal transplant recipients treated with and without basiliximab.
    Sugiyama K; Isogai K; Horisawa S; Toyama A; Satoh H; Saito K; Nakagawa Y; Tasaki M; Takahashi K; Hirano T
    Cell Transplant; 2012; 21(2-3):565-70. PubMed ID: 22793066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-free liver transplantation in children.
    Reding R; Gras J; Sokal E; Otte JB; Davies HF
    Lancet; 2003 Dec; 362(9401):2068-70. PubMed ID: 14697809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids.
    Asensio M; Margarit C; Chavez R; Ortega J; Charco R; Iglesias J
    Transplant Proc; 2002 Aug; 34(5):1970-1. PubMed ID: 12176650
    [No Abstract]   [Full Text] [Related]  

  • 19. Twenty-four hour steroid avoidance immunosuppressive regimen in liver transplant recipients.
    Ju WQ; Guo ZY; Ling X; He XS; Wu LW; Tai Q; Hu AB; Han M; Zhu XF
    Exp Clin Transplant; 2012 Jun; 10(3):258-62. PubMed ID: 22631063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of steroid-resistant acute liver transplant rejection with basiliximab.
    Fernandes ML; Lee YM; Sutedja D; Wai CT; Isacc J; Prabhakaran K; Lim SG; Lee KH
    Transplant Proc; 2005 Jun; 37(5):2179-80. PubMed ID: 15964372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.